Allworth Financial’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Hold
4,225
0.01% 669
2026
Q1
$702K Buy
4,225
+225
+6% +$36.9K ﹤0.01% 817
2025
Q4
$638K Sell
4,000
-225
-5% -$30.9K ﹤0.01% 835
2025
Q3
$396K Hold
4,225
﹤0.01% 980
2025
Q2
$240K Buy
4,225
+4,000
+1,778% +$212K ﹤0.01% 1104
2025
Q1
$12.7K Hold
225
﹤0.01% 2322
2024
Q4
$20.7K Buy
+225
New +$26.5K ﹤0.01% 2071

Other funds holding LABU

Allworth Financial's LABU Position: Q2 2026 in Review

Allworth Financial held its Direxion Daily S&P Biotech Bull 3X ETF (LABU) position steady in Q2 2026 at 4,225 shares worth $1.23M. The position accounts for 0.01% of the portfolio, ranked #669.

Allworth Financial first reported a position in LABU in Q4 2024 and has held it in 7 quarters since. 36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • Allworth Financial held 4,225 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $1.23M as of Q2 2026.
  • Allworth Financial left its Direxion Daily S&P Biotech Bull 3X ETF share count unchanged in Q2 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF made up 0.01% of Allworth Financial's portfolio in Q2 2026, its #669 holding.
  • Allworth Financial first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2024 and has held it in 7 quarters since.
  • 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.